- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Therapeutic Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Therapeutic Radiopharmaceuticals market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Thyroid accounting for % of the Therapeutic Radiopharmaceuticals global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Radium-223 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Therapeutic Radiopharmaceuticals include Bayer, Novartis, China Isotope & Radiation, Dongcheng, and Q BioMed, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Therapeutic Radiopharmaceuticals market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Radium-223
Lutetium-177
Iodine-131
Other
Market segment by Application can be divided into
Thyroid
Bone Metastasis
Lymphoma
Other
The key market players for global Therapeutic Radiopharmaceuticals market are listed below:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Radiopharmaceuticals, with price, sales, revenue and global market share of Therapeutic Radiopharmaceuticals from 2019 to 2022.
Chapter 3, the Therapeutic Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Therapeutic Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Radiopharmaceuticals.
Chapter 13, 14, and 15, to describe Therapeutic Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Therapeutic Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Radiopharmaceuticals Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Radiopharmaceuticals Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Radiopharmaceuticals Market Size & Forecast
1.4.1 Global Therapeutic Radiopharmaceuticals Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Therapeutic Radiopharmaceuticals Sales in Volume (2017-2028)
1.4.3 Global Therapeutic Radiopharmaceuticals Price (2017-2028)
1.5 Global Therapeutic Radiopharmaceuticals Production Capacity Analysis
1.5.1 Global Therapeutic Radiopharmaceuticals Total Production Capacity (2017-2028)
1.5.2 Global Therapeutic Radiopharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Therapeutic Radiopharmaceuticals Market Drivers
1.6.2 Therapeutic Radiopharmaceuticals Market Restraints
1.6.3 Therapeutic Radiopharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Therapeutic Radiopharmaceuticals Product and Services
2.1.4 Bayer Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Therapeutic Radiopharmaceuticals Product and Services
2.2.4 Novartis Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 China Isotope & Radiation
2.3.1 China Isotope & Radiation Details
2.3.2 China Isotope & Radiation Major Business
2.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product and Services
2.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Dongcheng
2.4.1 Dongcheng Details
2.4.2 Dongcheng Major Business
2.4.3 Dongcheng Therapeutic Radiopharmaceuticals Product and Services
2.4.4 Dongcheng Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Q BioMed
2.5.1 Q BioMed Details
2.5.2 Q BioMed Major Business
2.5.3 Q BioMed Therapeutic Radiopharmaceuticals Product and Services
2.5.4 Q BioMed Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Curium Pharmaceuticals
2.6.1 Curium Pharmaceuticals Details
2.6.2 Curium Pharmaceuticals Major Business
2.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
2.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Jubilant DraxImage
2.7.1 Jubilant DraxImage Details
2.7.2 Jubilant DraxImage Major Business
2.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Product and Services
2.7.4 Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business
2.8.3 Lantheus Therapeutic Radiopharmaceuticals Product and Services
2.8.4 Lantheus Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Spectrum Pharmaceuticals
2.9.1 Spectrum Pharmaceuticals Details
2.9.2 Spectrum Pharmaceuticals Major Business
2.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
2.9.4 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Progenics Pharmaceuticals
2.10.1 Progenics Pharmaceuticals Details
2.10.2 Progenics Pharmaceuticals Major Business
2.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
2.10.4 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 International Isotopes
2.11.1 International Isotopes Details
2.11.2 International Isotopes Major Business
2.11.3 International Isotopes Therapeutic Radiopharmaceuticals Product and Services
2.11.4 International Isotopes Therapeutic Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Therapeutic Radiopharmaceuticals Breakdown Data by Manufacturer
3.1 Global Therapeutic Radiopharmaceuticals Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Therapeutic Radiopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Therapeutic Radiopharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Therapeutic Radiopharmaceuticals Manufacturer Market Share in 2021
3.4.2 Top 6 Therapeutic Radiopharmaceuticals Manufacturer Market Share in 2021
3.5 Global Therapeutic Radiopharmaceuticals Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Therapeutic Radiopharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Therapeutic Radiopharmaceuticals Market Size by Region
4.1.1 Global Therapeutic Radiopharmaceuticals Sales in Volume by Region (2017-2028)
4.1.2 Global Therapeutic Radiopharmaceuticals Revenue by Region (2017-2028)
4.2 North America Therapeutic Radiopharmaceuticals Revenue (2017-2028)
4.3 Europe Therapeutic Radiopharmaceuticals Revenue (2017-2028)
4.4 Asia-Pacific Therapeutic Radiopharmaceuticals Revenue (2017-2028)
4.5 South America Therapeutic Radiopharmaceuticals Revenue (2017-2028)
4.6 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Therapeutic Radiopharmaceuticals Sales in Volume by Type (2017-2028)
5.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2017-2028)
5.3 Global Therapeutic Radiopharmaceuticals Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Therapeutic Radiopharmaceuticals Sales in Volume by Application (2017-2028)
6.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2017-2028)
6.3 Global Therapeutic Radiopharmaceuticals Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
7.2 North America Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
7.3 North America Therapeutic Radiopharmaceuticals Market Size by Country
7.3.1 North America Therapeutic Radiopharmaceuticals Sales in Volume by Country (2017-2028)
7.3.2 North America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
8.2 Europe Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
8.3 Europe Therapeutic Radiopharmaceuticals Market Size by Country
8.3.1 Europe Therapeutic Radiopharmaceuticals Sales in Volume by Country (2017-2028)
8.3.2 Europe Therapeutic Radiopharmaceuticals Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
9.2 Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
9.3 Asia-Pacific Therapeutic Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Therapeutic Radiopharmaceuticals Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
10.2 South America Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
10.3 South America Therapeutic Radiopharmaceuticals Market Size by Country
10.3.1 South America Therapeutic Radiopharmaceuticals Sales in Volume by Country (2017-2028)
10.3.2 South America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Type (2017-2028)
11.2 Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Application (2017-2028)
11.3 Middle East & Africa Therapeutic Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Therapeutic Radiopharmaceuticals Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Therapeutic Radiopharmaceuticals and Key Manufacturers
12.2 Manufacturing Costs Percentage of Therapeutic Radiopharmaceuticals
12.3 Therapeutic Radiopharmaceuticals Production Process
12.4 Therapeutic Radiopharmaceuticals Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Therapeutic Radiopharmaceuticals Typical Distributors
13.3 Therapeutic Radiopharmaceuticals Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Therapeutic Radiopharmaceuticals Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Therapeutic Radiopharmaceuticals Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Therapeutic Radiopharmaceuticals Product and Services
Table 6. Bayer Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Therapeutic Radiopharmaceuticals Product and Services
Table 10. Novartis Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 12. China Isotope & Radiation Major Business
Table 13. China Isotope & Radiation Therapeutic Radiopharmaceuticals Product and Services
Table 14. China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 16. Dongcheng Major Business
Table 17. Dongcheng Therapeutic Radiopharmaceuticals Product and Services
Table 18. Dongcheng Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 20. Q BioMed Major Business
Table 21. Q BioMed Therapeutic Radiopharmaceuticals Product and Services
Table 22. Q BioMed Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Curium Pharmaceuticals Major Business
Table 25. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
Table 26. Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table 28. Jubilant DraxImage Major Business
Table 29. Jubilant DraxImage Therapeutic Radiopharmaceuticals Product and Services
Table 30. Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Lantheus Basic Information, Manufacturing Base and Competitors
Table 32. Lantheus Major Business
Table 33. Lantheus Therapeutic Radiopharmaceuticals Product and Services
Table 34. Lantheus Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Spectrum Pharmaceuticals Major Business
Table 37. Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
Table 38. Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Progenics Pharmaceuticals Major Business
Table 41. Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Product and Services
Table 42. Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 44. International Isotopes Major Business
Table 45. International Isotopes Therapeutic Radiopharmaceuticals Product and Services
Table 46. International Isotopes Therapeutic Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Therapeutic Radiopharmaceuticals Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Therapeutic Radiopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Therapeutic Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Therapeutic Radiopharmaceuticals Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Therapeutic Radiopharmaceuticals Production Site of Key Manufacturer
Table 52. Therapeutic Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 53. Therapeutic Radiopharmaceuticals Mergers & Acquisitions in the Past Five Years
Table 54. Global Therapeutic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 55. Global Therapeutic Radiopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 56. Global Therapeutic Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Therapeutic Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 59. Global Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 60. Global Therapeutic Radiopharmaceuticals Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Therapeutic Radiopharmaceuticals Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Therapeutic Radiopharmaceuticals Price by Type (2017-2022) & (USD/Unit)
Table 63. Global Therapeutic Radiopharmaceuticals Price by Type (2023-2028) & (USD/Unit)
Table 64. Global Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 65. Global Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 66. Global Therapeutic Radiopharmaceuticals Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Therapeutic Radiopharmaceuticals Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Therapeutic Radiopharmaceuticals Price by Application (2017-2022) & (USD/Unit)
Table 69. Global Therapeutic Radiopharmaceuticals Price by Application (2023-2028) & (USD/Unit)
Table 70. North America Therapeutic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 71. North America Therapeutic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 72. North America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Therapeutic Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 75. North America Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 76. North America Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 77. North America Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 78. Europe Therapeutic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 79. Europe Therapeutic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 80. Europe Therapeutic Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Therapeutic Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 83. Europe Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 84. Europe Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 85. Europe Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 94. South America Therapeutic Radiopharmaceuticals Sales by Country (2017-2022) & (K Units)
Table 95. South America Therapeutic Radiopharmaceuticals Sales by Country (2023-2028) & (K Units)
Table 96. South America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Therapeutic Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 99. South America Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 100. South America Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 101. South America Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Therapeutic Radiopharmaceuticals Sales by Application (2023-2028) & (K Units)
Table 110. Therapeutic Radiopharmaceuticals Raw Material
Table 111. Key Manufacturers of Therapeutic Radiopharmaceuticals Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Therapeutic Radiopharmaceuticals Typical Distributors
Table 115. Therapeutic Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. Therapeutic Radiopharmaceuticals Picture
Figure 2. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type in 2021
Figure 3. Radium-223
Figure 4. Lutetium-177
Figure 5. Iodine-131
Figure 6. Other
Figure 7. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application in 2021
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Global Therapeutic Radiopharmaceuticals Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Therapeutic Radiopharmaceuticals Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Therapeutic Radiopharmaceuticals Sales (2017-2028) & (K Units)
Figure 15. Global Therapeutic Radiopharmaceuticals Price (2017-2028) & (USD/Unit)
Figure 16. Global Therapeutic Radiopharmaceuticals Production Capacity (2017-2028) & (K Units)
Figure 17. Global Therapeutic Radiopharmaceuticals Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Therapeutic Radiopharmaceuticals Market Drivers
Figure 19. Therapeutic Radiopharmaceuticals Market Restraints
Figure 20. Therapeutic Radiopharmaceuticals Market Trends
Figure 21. Global Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturer in 2021
Figure 22. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Manufacturer in 2021
Figure 23. Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Therapeutic Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Therapeutic Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 27. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 28. North America Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 29. Europe Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 31. South America Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 33. Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 34. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 35. Global Therapeutic Radiopharmaceuticals Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 37. Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 38. Global Therapeutic Radiopharmaceuticals Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 40. North America Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 41. North America Therapeutic Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 42. North America Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 43. United States Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 47. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 48. Europe Therapeutic Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 49. Europe Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 50. Germany Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Therapeutic Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 59. China Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 66. South America Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 67. South America Therapeutic Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 68. South America Therapeutic Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Therapeutic Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Therapeutic Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Therapeutic Radiopharmaceuticals in 2021
Figure 80. Manufacturing Process Analysis of Therapeutic Radiopharmaceuticals
Figure 81. Therapeutic Radiopharmaceuticals Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
